Search - tctmd.com

Displaying 281 - 290 of 290

Sort: Relevancy | Date

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

News Daily News

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

May 07, 2014

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

Presentation TCT 2012

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Presenter: Weon Kim, Won-Yu Kang, Jong-Shin Woo

January 03, 2012

Presentation TCT 2012

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Presenter: Joseph Kim, Helen Vlachos, Suresh R. Mulukutla, Catalin Toma, Joon S. Lee, David O. Williams, Sheryl F. Kelsey, Kevin E. Kip, Oscar C. Marroquin

January 03, 2012

News Daily News

Frailty Status Improves Prediction of Long-term Outcomes in PCI Patients

Caitlin E. Cox

September 09, 2011

News Daily News

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Caitlin E. Cox

August 19, 2011

News Daily News

Early Bolus of Sodium Bicarb Reduces Contrast Nephropathy in Emergent PCI

Jason Kahn

March 02, 2011

Advertisement

Access Site and the Risk of Acute Kidney Injury

Clinical Trial Updates: RenalGuard, AVERT, etc.

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Frailty Status Improves Prediction of Long-term Outcomes in PCI Patients

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Early Bolus of Sodium Bicarb Reduces Contrast Nephropathy in Emergent PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content